Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
36m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
1h agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Bioage Labs, Inc logo

Bioage Labs, Inc

About

Bioage Labs, Inc (NASDAQ:BIOA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 21 2026
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
Apr 13 2026
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Mar 24 2026
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
Feb 19 2026
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 9 2026
BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China

Financials

Revenue
$8.99 M
Market Cap
$777.98 M
EPS
-2.24

Community Chat

Ask AI

6ix6ixAIEvents